Targeting hyperactivated DNA-PKcs by KU0060648 inhibits glioma progression and enhances temozolomide therapy via suppression of AKT signaling

The overall survival remains undesirable in clinical glioma treatment. Inhibition of DNA-PKcs activity by its inhibitors suppresses tumor growth and enhances chemosensitivity of several tumors to chemotherapy. However, whether DNA-PKcs could be a potential target in glioma therapy remains unknown. I...

Descripción completa

Detalles Bibliográficos
Autores principales: Lan, Tian, Zhao, Zitong, Qu, Yanming, Zhang, Mingshan, Wang, Haoran, Zhang, Zhihua, Zhou, Wei, Fan, Xinyi, Yu, Chunjiang, Zhan, Qimin, Song, Yongmei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342436/
https://www.ncbi.nlm.nih.gov/pubmed/27487130
http://dx.doi.org/10.18632/oncotarget.10864

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342436/
https://www.ncbi.nlm.nih.gov/pubmed/27487130
http://dx.doi.org/10.18632/oncotarget.10864

Ejemplares similares